Plus   Neg

Eli Lilly Requests FDA Revoke EUA For Bamlanivimab 700 Mg Alone - Quick Facts

Eli Lilly and Company (LLY) has requested the FDA revoke the Emergency Use Authorization for bamlanivimab 700 mg alone. This is the final step in the company's transition to only supply bamlanivimab and etesevimab for administration together in the U.S. for the treatment of COVID-19. The company noted that the request is not due to any new safety concern.

Lilly's bamlanivimab was the first neutralizing monoclonal antibody to receive emergency use authorization from the FDA as a treatment for mild to moderate COVID-19. Lilly said all sites in the U.S. now have access to obtain doses of etesevimab for administration with bamlanivimab — which together neutralize more of the emerging COVID-19 variants in the U.S. than bamlanivimab alone.

Lilly, in collaboration with Amgen, plans to manufacture sufficient supply of bamlanivimab and etesevimab together. Lilly will submit only bamlanivimab administered with etesevimab together for authorization globally with a full transition expected by June 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
Follow RTT